The Pharmaceutical Out-licensing Course
With David Scott
Course Details
Out-licensing an R&D compound is a complex process with high stakes.
When negotiating with seasoned business development executives, preparation is critical to yield the best possible deal.
The goal of this course is to equip biotech and pharma executives with the tools and best practices to prepare for and execute every step of the process.
By participating, you will not only have the chance to ask your specific questions of a true expert, but also experience the unique opportunity to share experiences and engage in in-depth discussions with your international peers.
A valuable opportunity to understand and gain insights into the foundations of licensing in the biotech and pharmaceutical industry.
Basilea
Tom Wyckmans, Corporate Development Analyst - Switzerland
Critical initial planning decisions, such as timing and deal type.
Templates and dos & don’ts of critical documents, such as CDAs, MTAs and term sheets.
How to set up a spreadsheet to simulate the value and determine the optimal commercial structure of the deal.
How to maximise your attractiveness to potential licensing partners.
How to target licensees who are more likely to pay a premium.
Understand the due diligence process and what will be expected of you.
This course provides you with several aspects of licensing from zero. It is very well organised and our teacher was very experienced and approachable. The course also provided an opportunity to network with other people who work in the same field! I highly recommend it to anyone interested in learning more about the out-licensing process in the pharma industry.
Laboratorios Azevedos
Ana Patricia Monteiro, International Business Development - Portugal
| Welcome & General Introduction (~15 min) |
|
| Preparing the Ground: Strategy & Planning (~45 min) |
|
| Deciding What Type of Deal to Seek (~45 min) |
|
| The Legal Agreements You Will Encounter in a Licensing Deal: Templates - Points of Caution - Do’s & don’ts (~1 h 45 min) |
|
| Lunch Break |
| Valuing the Deal With the rNPV model (~45 min) |
|
| Preparing to Out-license: The Action Plan - The Team (~30 min) |
|
| How to Prepare the Out-licensing Marketing Material (~45 min) |
|
| Preparing a Target Term Sheet (~30 min) |
|
| Finding and Attracting the Right Partners (~45 min) |
|
Formerly a pharma Business Development & Licensing executive, David Scott has worked as a Senior BD&L Consultant since 1996.
He has concluded numerous inward and outward licensing agreements for clients covering small molecules, biologicals, and delivery technologies.
David is the author of Scrip’s best-selling report "Practical Guide to Pharmaceutical Licensing".
With a strong track record in running successful training courses and workshops, David has a no-nonsense, hands-on approach to training.
A wonderful training. Very insightful, very valuable. David is a great instructor. Besides his experience in BD, he is also a phenomenal storyteller which kept us engaged and excited to learn, thanks a lot!
Ferring
Akin Kurtoglu, Head of Evaluation & Due Diligence, Global Business Development - Denmark
The Pharmaceutical Out-licensing Course is designed for those likely to be involved in the out-licensing process of a development product:
Senior executives and scientists in companies developing or planning to develop products for out-licensing.
Junior to mid-level managers, including scientists, commercial and legal managers, who are likely to be involved in the licensing and due diligence process.
Business development managers, members of legal and IP teams with no formal training in licensing and staff joining the business development and licensing functions.
Managers looking to broaden their personal career skills with a thorough understanding of the out-licensing process.
Would you like to receive a list of anonymised participant profiles from previous sessions?
Email Annelies Swaan
UPCOMING DATES & FORMATS - FEES
14 November 2025
Live online (CET timing)
Early bird € 1 470
(until 10/10/2025)
(Full fee € 1 670)
TIMING & LOCATION
Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
SPECIAL OFFER FOR BIOTECH EXECUTIVES
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan, Director Business Operations, for more details.
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
You will receive a digital copy of the checklists, templates and valuation tool used in this course so you can immediately use them when back in the office
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
8,8/10!
Testimonials from past participants:
This course provides you with several aspects of licensing from zero. It is very well organised and our teacher was very experienced and approachable. The course also provided an opportunity to network with other people who work in the same field! I highly recommend it to anyone interested in learning more about the out-licensing process in the pharma industry.
Laboratorios Azevedos
Ana Patricia Monteiro, International Business Development - Portugal - December 2023
A valuable opportunity to understand and gain insights into the foundations of licensing in the biotech and pharmaceutical industry.
Basilea
Tom Wyckmans, Corporate Development Analyst - Switzerland - December 2023
A wonderful training. Very insightful, very valuable. David is a great instructor. Besides his experience in BD, he is also a phenomenal storyteller which kept us engaged and excited to learn, thanks a lot!
Ferring
Akin Kurtoglu, Head of Evaluation & Due Diligence, Global Business Development - Denmark - June 2023
Attending this course is a good starting point for someone aiming to get themselves started in the licensing business. You can learn a lot from David through him sharing his vast experiences, and also the experiences shared by the other participants. The role-plays are definitely an added plus to practice the course learnings. Overall, the interaction online worked well. Thank you for a very well organised and very enjoyable course!
RPH Pharmaceuticals
Sergio Gil, Business Development Director - Spain - June 2023
I found the CELforPharma Pharmaceutical Out-licensing Course very interesting and enjoyed the opportunity to connect with BusDev colleagues from around the world. The organisation was top-notch and our expert-trainer very entertaining. Many thanks to all of you!
AGS Therapeutics
Marie-Hélène Leopold, Co-Founder, Chief Corporate Development Officer - France - November 2022
The course gives a very good insight on the overall out-licensing process. It equips you with all major topics so that you can start creating the process you need for your work.
medac
Nadja Auer, Senior BD & Out-licensing Manager; Global Business Innovative Drugs - Germany - November 2022
Very useful introduction and overview of out-licensing activity in the pharmaceutical industry!
Faes Farma
María Junco Burgos, Out-Licensing Dept. - Spain - October 2022
It was great to learn from someone like David who has so much experience in licensing.
Immutep
Domonkos Vince Varga, Business Development Manager - Germany - May 2022
A great course for business managers, either with in- or out- licensing roles. Specially dedicated to innovative technologies and novel drugs, it allows the participant to broaden perspectives about the licensing process and all related aspects. Learning from an experienced speaker like David was a very fruitful way of learning how to think strategically and how to plan future partnerships.
Bluepharma
Jorge Espírito Santo, Business Development - Portugal - May 2022
Very practical real-world advice and tools for everyday use in the field of drug out-licensing.
Kora Healthcare
Shane Fitzgerald, Commercial Director ROI & ROW - Ireland - May 2022
Well-structured course with a very experienced instructor.
Curasight
Ulrich Krasilnikoff, CEO - Denmark - May 2022
The course was great, and David Scott has an excellent experience that he shared with us, which improved my knowledge very effectively. I will recommend it.
Italfarmaco
Laura Sala, Out Licensing Director - Italy - December 2021
This course is very well structured, including hands-on content and practice-oriented exercises. David is a highly experienced professional in out-licensing deals. One of the essential courses for gaining best practice guidance on out-licensing.
NEUWAY Pharma
Oliver Ernst, Managing Director - Germany - December 2021
It was a very interesting course taught by an experienced teacher that was able to provide practical information based on knowledge and past experience. Easy to follow and truly recommendable.
Bioiberica
Oriol Huguet Gonzalez, Business Development & Innovation Partnership - Spain - December 2021
David was a very knowledgeable instructor, and did well covering a lot of ground in a short time.
BenevolentAI
Billy West, Business Development Executive - United Kingdom - May 2021
It is really a good course to have an overall knowledge of how out-licensing works. I enjoyed learning not only from the expert, but also from the other participants in the group. Thank you David for the great course and thanks to CELforPharma for the excellent service and communication!
Polfa Tarchomin
Marta Moszkowicz, Export Manager - Poland - May 2021
Very well-structured course with many relevant examples. The expert, David Scott, is very knowledgeable and a great speaker.
Sanquin
Vanessa Tarta, Business Development Manager - The Netherlands - May 2021
People attending this course are typically also interested in:
Course Details
Dates & Locations
Special offer for biotech start-ups & academia: Apply for a € 400 discount. Contact Annelies Swaan for more details.
Upcoming Session
14 November 2025, Live online (CET timing)
Early bird € 1 470
(until 10/10/2025)
(Full fee € 1 670)
Prices are excl. VAT
Out-licensing an R&D compound is a complex process with high stakes.
When negotiating with seasoned business development executives, preparation is critical to yield the best possible deal.
The goal of this course is to equip biotech and pharma executives with the tools and best practices to prepare for and execute every step of the process.
By participating, you will not only have the chance to ask your specific questions of a true expert, but also experience the unique opportunity to share experiences and engage in in-depth discussions with your international peers.
A valuable opportunity to understand and gain insights into the foundations of licensing in the biotech and pharmaceutical industry.
Basilea
Tom Wyckmans, Corporate Development Analyst - Switzerland
Critical initial planning decisions, such as timing and deal type.
Templates and dos & don’ts of critical documents, such as CDAs, MTAs and term sheets.
How to set up a spreadsheet to simulate the value and determine the optimal commercial structure of the deal.
How to maximise your attractiveness to potential licensing partners.
How to target licensees who are more likely to pay a premium.
Understand the due diligence process and what will be expected of you.
This course provides you with several aspects of licensing from zero. It is very well organised and our teacher was very experienced and approachable. The course also provided an opportunity to network with other people who work in the same field! I highly recommend it to anyone interested in learning more about the out-licensing process in the pharma industry.
Laboratorios Azevedos
Ana Patricia Monteiro, International Business Development - Portugal
| Welcome & General Introduction (~15 min) |
|
| Preparing the Ground: Strategy & Planning (~45 min) |
|
| Deciding What Type of Deal to Seek (~45 min) |
|
| The Legal Agreements You Will Encounter in a Licensing Deal: Templates - Points of Caution - Do’s & don’ts (~1 h 45 min) |
|
| Lunch Break |
| Valuing the Deal With the rNPV model (~45 min) |
|
| Preparing to Out-license: The Action Plan - The Team (~30 min) |
|
| How to Prepare the Out-licensing Marketing Material (~45 min) |
|
| Preparing a Target Term Sheet (~30 min) |
|
| Finding and Attracting the Right Partners (~45 min) |
|
Formerly a pharma Business Development & Licensing executive, David Scott has worked as a Senior BD&L Consultant since 1996.
He has concluded numerous inward and outward licensing agreements for clients covering small molecules, biologicals, and delivery technologies.
David is the author of Scrip’s best-selling report "Practical Guide to Pharmaceutical Licensing".
With a strong track record in running successful training courses and workshops, David has a no-nonsense, hands-on approach to training.
A wonderful training. Very insightful, very valuable. David is a great instructor. Besides his experience in BD, he is also a phenomenal storyteller which kept us engaged and excited to learn, thanks a lot!
Ferring
Akin Kurtoglu, Head of Evaluation & Due Diligence, Global Business Development - Denmark
The Pharmaceutical Out-licensing Course is designed for those likely to be involved in the out-licensing process of a development product:
Senior executives and scientists in companies developing or planning to develop products for out-licensing.
Junior to mid-level managers, including scientists, commercial and legal managers, who are likely to be involved in the licensing and due diligence process.
Business development managers, members of legal and IP teams with no formal training in licensing and staff joining the business development and licensing functions.
Managers looking to broaden their personal career skills with a thorough understanding of the out-licensing process.
Would you like to receive a list of anonymised participant profiles from previous sessions?
Email Annelies Swaan
UPCOMING DATES & FORMATS - FEES
14 November 2025
Live online (CET timing)
Early bird € 1 470
(until 10/10/2025)
(Full fee € 1 670)
TIMING & LOCATION
Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
SPECIAL OFFER FOR BIOTECH EXECUTIVES
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan, Director Business Operations, for more details.
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
You will receive a digital copy of the checklists, templates and valuation tool used in this course so you can immediately use them when back in the office
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
8,8/10!
Testimonials from past participants:
This course provides you with several aspects of licensing from zero. It is very well organised and our teacher was very experienced and approachable. The course also provided an opportunity to network with other people who work in the same field! I highly recommend it to anyone interested in learning more about the out-licensing process in the pharma industry.
Laboratorios Azevedos
Ana Patricia Monteiro, International Business Development - Portugal - December 2023
A valuable opportunity to understand and gain insights into the foundations of licensing in the biotech and pharmaceutical industry.
Basilea
Tom Wyckmans, Corporate Development Analyst - Switzerland - December 2023
A wonderful training. Very insightful, very valuable. David is a great instructor. Besides his experience in BD, he is also a phenomenal storyteller which kept us engaged and excited to learn, thanks a lot!
Ferring
Akin Kurtoglu, Head of Evaluation & Due Diligence, Global Business Development - Denmark - June 2023
Attending this course is a good starting point for someone aiming to get themselves started in the licensing business. You can learn a lot from David through him sharing his vast experiences, and also the experiences shared by the other participants. The role-plays are definitely an added plus to practice the course learnings. Overall, the interaction online worked well. Thank you for a very well organised and very enjoyable course!
RPH Pharmaceuticals
Sergio Gil, Business Development Director - Spain - June 2023
I found the CELforPharma Pharmaceutical Out-licensing Course very interesting and enjoyed the opportunity to connect with BusDev colleagues from around the world. The organisation was top-notch and our expert-trainer very entertaining. Many thanks to all of you!
AGS Therapeutics
Marie-Hélène Leopold, Co-Founder, Chief Corporate Development Officer - France - November 2022
The course gives a very good insight on the overall out-licensing process. It equips you with all major topics so that you can start creating the process you need for your work.
medac
Nadja Auer, Senior BD & Out-licensing Manager; Global Business Innovative Drugs - Germany - November 2022
Very useful introduction and overview of out-licensing activity in the pharmaceutical industry!
Faes Farma
María Junco Burgos, Out-Licensing Dept. - Spain - October 2022
It was great to learn from someone like David who has so much experience in licensing.
Immutep
Domonkos Vince Varga, Business Development Manager - Germany - May 2022
A great course for business managers, either with in- or out- licensing roles. Specially dedicated to innovative technologies and novel drugs, it allows the participant to broaden perspectives about the licensing process and all related aspects. Learning from an experienced speaker like David was a very fruitful way of learning how to think strategically and how to plan future partnerships.
Bluepharma
Jorge Espírito Santo, Business Development - Portugal - May 2022
Very practical real-world advice and tools for everyday use in the field of drug out-licensing.
Kora Healthcare
Shane Fitzgerald, Commercial Director ROI & ROW - Ireland - May 2022
Well-structured course with a very experienced instructor.
Curasight
Ulrich Krasilnikoff, CEO - Denmark - May 2022
The course was great, and David Scott has an excellent experience that he shared with us, which improved my knowledge very effectively. I will recommend it.
Italfarmaco
Laura Sala, Out Licensing Director - Italy - December 2021
This course is very well structured, including hands-on content and practice-oriented exercises. David is a highly experienced professional in out-licensing deals. One of the essential courses for gaining best practice guidance on out-licensing.
NEUWAY Pharma
Oliver Ernst, Managing Director - Germany - December 2021
It was a very interesting course taught by an experienced teacher that was able to provide practical information based on knowledge and past experience. Easy to follow and truly recommendable.
Bioiberica
Oriol Huguet Gonzalez, Business Development & Innovation Partnership - Spain - December 2021
David was a very knowledgeable instructor, and did well covering a lot of ground in a short time.
BenevolentAI
Billy West, Business Development Executive - United Kingdom - May 2021
It is really a good course to have an overall knowledge of how out-licensing works. I enjoyed learning not only from the expert, but also from the other participants in the group. Thank you David for the great course and thanks to CELforPharma for the excellent service and communication!
Polfa Tarchomin
Marta Moszkowicz, Export Manager - Poland - May 2021
Very well-structured course with many relevant examples. The expert, David Scott, is very knowledgeable and a great speaker.
Sanquin
Vanessa Tarta, Business Development Manager - The Netherlands - May 2021
People attending this course are typically also interested in: